← Back to Browse
ProductDiagnostic Tests

CRISPR-Based Diagnostics Platform

United States

IntelliGenome's proprietary CRISPR technology platform for decentralized diagnostics. Accurately detects pathogens and monitors treatment response across multiple applications including TB and oncology.

Manufactured by

Intelligenome

United States

IntelliGenome develops diagnostic technology for serious health challenges with a vision to create a diagnostic platform that transforms the lives of people impacted by infectious disease. The company has developed and validated ultra-sensitive CRISPR-based detection of low abundance nucleic acid in small volume blood samples.

View profile & products →

✦ Product-Specific Coverage

AI supplier coverage for this product

Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.

Generated for this product

AI-matched supplier coverage based on related product alternatives.

0
Relevant manufacturers
matched to this product
0
Relevant products analyzed
for supplier coverage
0
Sourcing countries
identified

Top sourcing countries

1China
21 relevant products
2South Korea
11 relevant products
3United States
6 relevant products
🔒

11 more sourcing countries available

Get free access to all sourcing countries identified for this product.

See all countries →

See the full supplier coverage for this product

Get free access to all relevant manufacturers, sourcing countries, and product alternatives.

Get Free Access →

Free for medical industry professionals.

AI-Matched Alternative Products

from other manufacturers

AI-Matched Alternative Products

from other manufacturers

3 of 58 closest product alternatives

58 products

55 more product alternatives available

Create a free account to compare more product alternatives and supplier options.

Get Free Access →

© 2026 Suplivia · Home · Browse Products